(Q44403127)

2 December 2017

A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth (English)

1 reference

2 December 2017

1 reference

4

Ulrich Kintscher

1 reference

2 December 2017

Dennis Bruemmer

1

1 reference

2 December 2017

Joel P Berger

2

1 reference

2 December 2017

Joey Liu

3

1 reference

2 December 2017

Shu Wakino

5

1 reference

2 December 2017

Eckart Fleck

6

1 reference

2 December 2017

David E Moller

7

1 reference

2 December 2017

Ronald E Law

8

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

European Journal of Pharmacology

2 December 2017

1 reference

2 December 2017

466

1 reference

2 December 2017

3

1 reference

2 December 2017

225-234

1 reference

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Differentiating members of the thiazolidinedione class: a focus on safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

New drug targets for type 2 diabetes and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Principles of CDK regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

PPAR gamma and the treatment of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Cell biology of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Critical roles of PPAR beta/delta in keratinocyte response to inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

E2F and cell proliferation: a world turned upside down

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901556-5

10.1016/S0014-2999(03)01556-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference